Brain research bulletin · 2026
Glymphatic system dysfunction and cognitive impairment in post-chemotherapy AML: A novel DTI-ALPS index study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Peng, Li Ying, Zhang Yifei, Sun Chuang, Yang Yan, Kang Zhijie, Wang Ying, Huang Yanan, Xu Zilin, Zhao Yue, Chen Honghai, Qin Dongxue, Yan Jinsong, Cao Yuhai
Аннотация
BACKGROUND: This study aimed to evaluate glymphatic function using the diffusion tensor imaging along the perivascular spaces (DTI-ALPS) index in patients with acute myeloid leukemia (AML) following chemotherapy and to explore its association with cognitive performance.
METHODS: Twenty-one AML patients were assessed 4-8 weeks after their final chemotherapy cycle (PC-AML), along with 20 age- and sex-matched healthy controls (HCs). All participants underwent brain MRI and cognitive assessment. Imaging metrics included cerebrospinal fluid (CSF) volume, basal ganglia perivascular space (BG-PVS) volume fraction, DTI-ALPS index, and blood oxygen level-dependent-CSF coupling. Group comparisons and correlations between glymphatic markers and cognitive scores were analyzed.
RESULTS: Post-chemotherapy AML patients exhibited significantly increased CSF volume (PFDR = 0.046) and BG-PVS volume(PFDR = 0.040), alongside a reduced DTI-ALPS index(PFDR = 0.046). Cognitive performance was significantly impaired, with lower Mini-Mental State Examination (MMSE; P < 0.01) and Montreal Cognitive Assessment (MoCA; P < 0.01) scores, and higher Activities of Daily Living (ADL) scores (P < 0.01). BG-PVS volume correlated inversely with MMSE (r = -0.467, P = 0.002) and MoCA (r = -0.396, P = 0.010), while the DTI-ALPS index positively correlated with MoCA (r = 0.417, P = 0.006).
CONCLUSION: Post-chemotherapy AML patients exhibit glymphatic system dysfunction and cognitive decline, with a significant association between these alterations. Impairment in glymphatic function, as suggested by these biomarkers, may contribute to cognitive deficits in this context. The DTI-ALPS index and BG-PVS volume represent potential neuroimaging biomarkers, providing new insights into chemotherapy-related cognitive impairment in AML.
METHODS: Twenty-one AML patients were assessed 4-8 weeks after their final chemotherapy cycle (PC-AML), along with 20 age- and sex-matched healthy controls (HCs). All participants underwent brain MRI and cognitive assessment. Imaging metrics included cerebrospinal fluid (CSF) volume, basal ganglia perivascular space (BG-PVS) volume fraction, DTI-ALPS index, and blood oxygen level-dependent-CSF coupling. Group comparisons and correlations between glymphatic markers and cognitive scores were analyzed.
RESULTS: Post-chemotherapy AML patients exhibited significantly increased CSF volume (PFDR = 0.046) and BG-PVS volume(PFDR = 0.040), alongside a reduced DTI-ALPS index(PFDR = 0.046). Cognitive performance was significantly impaired, with lower Mini-Mental State Examination (MMSE; P < 0.01) and Montreal Cognitive Assessment (MoCA; P < 0.01) scores, and higher Activities of Daily Living (ADL) scores (P < 0.01). BG-PVS volume correlated inversely with MMSE (r = -0.467, P = 0.002) and MoCA (r = -0.396, P = 0.010), while the DTI-ALPS index positively correlated with MoCA (r = 0.417, P = 0.006).
CONCLUSION: Post-chemotherapy AML patients exhibit glymphatic system dysfunction and cognitive decline, with a significant association between these alterations. Impairment in glymphatic function, as suggested by these biomarkers, may contribute to cognitive deficits in this context. The DTI-ALPS index and BG-PVS volume represent potential neuroimaging biomarkers, providing new insights into chemotherapy-related cognitive impairment in AML.